![PDF) Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG) PDF) Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG)](https://i1.rgstatic.net/publication/12670088_Stage-modified_international_prognostic_index_effectively_predicts_clinical_outcome_of_localized_primary_gastric_diffuse_large_B-cell_lymphoma_International_Extranodal_Lymphoma_Study_Group_IELSG/links/56deac4508aed4e2a99db3f5/largepreview.png)
PDF) Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG)
![Barbui Porte di Barbui Maurizio e C. S.a.s. - Via Roma, 27 - 33095 San Giorgio Della Richinvelda (PN) Barbui Porte di Barbui Maurizio e C. S.a.s. - Via Roma, 27 - 33095 San Giorgio Della Richinvelda (PN)](https://static.pgol.it/responsive/img/staticmap.png?minCheck=3000&x=12.8715&y=46.049&xpix=400&ypix=224&z=0.9&sito=PB&fi=png&lg=NO&mi=NO&type=N)
Barbui Porte di Barbui Maurizio e C. S.a.s. - Via Roma, 27 - 33095 San Giorgio Della Richinvelda (PN)
Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular | Hematology, Transfusion and Cell Therapy
![Frontiers | Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine Frontiers | Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine](https://www.frontiersin.org/files/Articles/1117815/fonc-13-1117815-HTML/image_m/fonc-13-1117815-g001.jpg)
Frontiers | Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine
![Frontiers | Janus Kinase-2 V617F Mutation and Antiphospholipid Syndrome in Cerebral Sinus Venous Thrombosis: Natural History and Retrospective Bicenter Analysis Frontiers | Janus Kinase-2 V617F Mutation and Antiphospholipid Syndrome in Cerebral Sinus Venous Thrombosis: Natural History and Retrospective Bicenter Analysis](https://www.frontiersin.org/files/Articles/783795/fneur-13-783795-HTML/image_m/fneur-13-783795-g001.jpg)
Frontiers | Janus Kinase-2 V617F Mutation and Antiphospholipid Syndrome in Cerebral Sinus Venous Thrombosis: Natural History and Retrospective Bicenter Analysis
From leeches to personalized medicine: evolving concepts in the management of polycythemia vera | Haematologica
![PDF) Evidence suggesting the presence of a stem cell clone anteceding the acquisition of the JAK2-V617F mutation | Denis-Claude Roy - Academia.edu PDF) Evidence suggesting the presence of a stem cell clone anteceding the acquisition of the JAK2-V617F mutation | Denis-Claude Roy - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42820490/mini_magick20190217-26295-7xclpr.png?1550398346)
PDF) Evidence suggesting the presence of a stem cell clone anteceding the acquisition of the JAK2-V617F mutation | Denis-Claude Roy - Academia.edu
![Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms - ScienceDirect Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121002871-fx1.jpg)
Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms - ScienceDirect
![Molecular pathogenesis of the myeloproliferative neoplasms | Journal of Hematology & Oncology | Full Text Molecular pathogenesis of the myeloproliferative neoplasms | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01116-z/MediaObjects/13045_2021_1116_Fig1_HTML.png)